iuvo Toxicologist Dr. Cheryl Marker Publishes Paper Related to Potential Opioid Treatment
iuvo BioScience Toxicologist Dr. Cheryl Marker was coauthor of a paper that was published in the February 2023 issue of Cell Reports entitled “A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl”. Dr. Marker works in the Lumino Advisors consulting group, as part of iuvo’s consulting team. Opioid […]